Icelandic HCV elimination program treats majority of viremic population
Since its launch in 2016, a hepatitis C elimination program in Iceland has treated approximately 56% to 70% of the estimated viremic population with direct-acting antivirals, according to a recently published update. “The idea was to offer DAAs to all HCV-positive patients within an entire population within a relatively short time frame and simultaneously initiate […]
Icelandic HCV elimination program treats majority of viremic population Read More »